Bausch & Lomb, Ciba Settlement Leaves No Outstanding Suits Between Firms

Bausch & Lomb will pay royalties on U.S. PureVision contact lens sales until 2014 under the terms of a silicone hydrogel technology cross-license with competitor Novartis/Ciba Vision